Literature DB >> 2100599

Method validation in the bioanalytical laboratory.

A R Buick1, M V Doig, S C Jeal, G S Land, R D McDowall.   

Abstract

Bioanalytical methods, based on a variety of physico-chemical and biological techniques such as chromatography, immunoassay and mass spectrometry, must be validated prior to and during use to engender confidence in the results generated. The fundamental criteria for assessing the reliability and overall performance of a bioanalytical method are: the evaluation of drug and analyte stability, selectivity, limits of quantification and detection, accuracy, precision, linearity and recovery. The extent to which a method is validated is dependent on its prospective use, the number of samples to be assayed and the use to which the data are put. Specific analytical techniques may require additional validation such as antibody-binding characteristics, peak purity determination, evaluation of matrix effects or structural confirmation of the analyte. Ideally each assay should be cross-validated with a method utilizing a highly specific detector such as a mass spectrometer. Once in use, the performance of the method should be monitored using quality control standards. If a method is set up in another laboratory, the performance of that assay should be monitored with quality control standards sent from the originating laboratory.

Mesh:

Year:  1990        PMID: 2100599     DOI: 10.1016/0731-7085(90)80093-5

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  8 in total

Review 1.  Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling.

Authors:  Linlin Zhao; Heather L Ciallella; Lauren M Aleksunes; Hao Zhu
Journal:  Drug Discov Today       Date:  2020-07-11       Impact factor: 7.851

2.  A liquid chromatography/mass spectrometric method for simultaneous analysis of arachidonic acid and its endogenous eicosanoid metabolites prostaglandins, dihydroxyeicosatrienoic acids, hydroxyeicosatetraenoic acids, and epoxyeicosatrienoic acids in rat brain tissue.

Authors:  Hongfei Yue; Susan A Jansen; Kenneth I Strauss; Michael R Borenstein; Mary F Barbe; Luella J Rossi; Elise Murphy
Journal:  J Pharm Biomed Anal       Date:  2006-11-27       Impact factor: 3.935

3.  The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants.

Authors:  Pierre Baumann; Sven Ulrich; Gabriel Eckermann; Manfred Gerlach; Hans-Joachim Kuss; Gerd Laux; Bruno Müller-Oerlinghausen; Marie Luise Rao; Peter Riederer; Gerald Zernig; Christoph Hiemke
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

4.  Determination of albendazole and metabolites in silkworm Bombyx mori hemolymph by ultrafast liquid chromatography tandem triple quadrupole mass spectrometry.

Authors:  Li Li; Dong-Xu Xing; Qing-Rong Li; Yang Xiao; Ming-Qiang Ye; Qiong Yang
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

5.  Optimization and Application of Direct Infusion Nanoelectrospray HRMS Method for Large-Scale Urinary Metabolic Phenotyping in Molecular Epidemiology.

Authors:  Elena Chekmeneva; Gonçalo Dos Santos Correia; Queenie Chan; Anisha Wijeyesekera; Adrienne Tin; Jeffery Hunter Young; Paul Elliott; Jeremy K Nicholson; Elaine Holmes
Journal:  J Proteome Res       Date:  2017-03-14       Impact factor: 4.466

6.  Fast and Accurate Pneumocystis Pneumonia Diagnosis in Human Samples Using a Label-Free Plasmonic Biosensor.

Authors:  Olalla Calvo-Lozano; Anna Aviñó; Vicente Friaza; Alfonso Medina-Escuela; César S Huertas; Enrique J Calderón; Ramón Eritja; Laura M Lechuga
Journal:  Nanomaterials (Basel)       Date:  2020-06-26       Impact factor: 5.076

7.  Methodologic issues in the validation of putative biomarkers and surrogate endpoints in treatment evaluation for systemic lupus erythematosus.

Authors:  Matthew H Liang; Julia F Simard; Karen Costenbader; Benjamin T Dore; Michael Ward; Paul R Fortin; Gabor G Illei; Susan Manzi; Barbara Mittleman; Jill Buyon; Samardeep Gupta; Michal Abrahamowicz
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2009-03       Impact factor: 2.895

8.  Benefits of a pharmacology antimalarial reference standard and proficiency testing program provided by the Worldwide Antimalarial Resistance Network (WWARN).

Authors:  Chris Lourens; Niklas Lindegardh; Karen I Barnes; Philippe J Guerin; Carol H Sibley; Nicholas J White; Joel Tarning
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.